Leukotriene biosynthesis inhibitors
- PMID: 24271120
- DOI: 10.1023/A:1016381215385
Leukotriene biosynthesis inhibitors
Abstract
This review describes the design and current development of leukotriene biosynthesis inhibitors as potential antiinflammatory agents. Knowledge of the enzymatic mechanism of 5-lipoxygenase led to specific inhibitors of this enzyme which catalyzes a key step in the leukotriene pathway. Competitive inhibitors include iron chelators, redox agents and alternate substrates. Further, the potential of product inhibitors and mechanism based inactivators of 5-lipoxygenase is discussed.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources